ES2077757T3 - Preparacion farmaceutica solida con disolucion rapida que contiene la s-(carboximetil)-l-cisteina y/o la n-acetilcisteina. - Google Patents

Preparacion farmaceutica solida con disolucion rapida que contiene la s-(carboximetil)-l-cisteina y/o la n-acetilcisteina.

Info

Publication number
ES2077757T3
ES2077757T3 ES91116899T ES91116899T ES2077757T3 ES 2077757 T3 ES2077757 T3 ES 2077757T3 ES 91116899 T ES91116899 T ES 91116899T ES 91116899 T ES91116899 T ES 91116899T ES 2077757 T3 ES2077757 T3 ES 2077757T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
cisteina
carboximetil
acetilcisteina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91116899T
Other languages
English (en)
Other versions
ES2077757T5 (es
Inventor
Rolf-Dieter Juch
Gerd Dr Birrenbach
Christian Dr Pflugshaupt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spirig Pharma AG
Original Assignee
Spirig AG Pharmazeutische Praeparate
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4253965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2077757(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Spirig AG Pharmazeutische Praeparate filed Critical Spirig AG Pharmazeutische Praeparate
Publication of ES2077757T3 publication Critical patent/ES2077757T3/es
Application granted granted Critical
Publication of ES2077757T5 publication Critical patent/ES2077757T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PREPARACION DE ALIMENTOS SOLIDOS Y COMPACTOS QUE CONTIENEN CISTEINA ACETILA DE N Y/O CISTEINA S-(CARBOXIMETILO)-L ES ADECUADA PARA TRAGAR, CHUPAR O PARA DISOLVERLAS EN AGUA O EN UNA SOLUCION ACUOSA, A PESAR DE QUE TIENE UNA PEQUEÑA PARTE DE SUSTANCIAS AUXILIARES. ESTOS MEDICAMENTOS SON TAN COMPACTOS DEBIDO A QUE TIENE UNA GRAN PARTE DE SUSTANCIAS ACTIVAS, DE MAS DEL 50% DE PESO DEL PESO TOTAL Y MEDIANTE LA ELECCION APROPIADA DE MEDIOS AUXILIARES DE PASTILLAS.
ES91116899T 1990-10-19 1991-10-04 Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina. Expired - Lifetime ES2077757T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH334590 1990-10-19

Publications (2)

Publication Number Publication Date
ES2077757T3 true ES2077757T3 (es) 1995-12-01
ES2077757T5 ES2077757T5 (es) 2001-06-01

Family

ID=4253965

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91116899T Expired - Lifetime ES2077757T5 (es) 1990-10-19 1991-10-04 Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.

Country Status (7)

Country Link
US (1) US5401514A (es)
EP (1) EP0481294B2 (es)
AT (1) ATE125702T1 (es)
DE (1) DE59106133D1 (es)
DK (1) DK0481294T4 (es)
ES (1) ES2077757T5 (es)
GR (1) GR3017499T3 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807894A (en) * 1992-12-02 1998-09-15 Zambon Group S.P.A. Syrup containing N-acetyl-cysteine
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9305058D0 (en) * 1993-03-12 1993-04-28 Penn Pharm Ltd Pharmaceutical compositions
SE9601527D0 (sv) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally alministered acetylcysteine as mucolytic agent
ES2118673T3 (es) * 1996-10-29 2001-04-16 Staroil Ltd Composiciones solubles en la boca que contienen n-acetilcisteina y ciclodextrina.
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
IT1311907B1 (it) * 1999-04-06 2002-03-20 Zambon Spa Compresse deglutibili ad alto contenuto di n-acetilcisteina.
CA2424770A1 (en) * 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
AU2002224053A1 (en) * 2000-11-21 2002-06-03 Kyorin Pharmaceutical Co. Ltd. Dry syrup preparations
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
RU2216320C1 (ru) * 2002-02-22 2003-11-20 Мануйлов Борис Михайлович Средство фарингал для профилактики и лечения инфекционно-воспалительных заболеваний ротоглотки
MXPA05003512A (es) * 2002-10-04 2005-06-03 Pharmacia Corp Composiciones y metodos para el tratamiento de la disfuncion sexual.
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7790928B1 (en) * 2005-04-25 2010-09-07 Albert Raymond Hechinger Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
CN102316730A (zh) * 2008-05-09 2012-01-11 天雅瑞药业有限公司 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
ES2716990T5 (es) 2013-12-23 2023-03-24 Dr Falk Pharma Gmbh Formulación farmacéutica optimizada para el tratamiento de cambios inflamatorios del esófago
RU2611411C1 (ru) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка ацетилцистеина и способ ее изготовления
CN108553439B (zh) * 2018-04-20 2020-10-16 广州白云山医药集团股份有限公司白云山制药总厂 一种含s-羧甲基-l-半胱氨酸的肠溶片剂
PH12018000390A1 (en) * 2018-11-20 2020-09-28 Novex Science Pte Ltd Carbocysteine and zinc tablet
US20220175851A1 (en) * 2019-03-13 2022-06-09 The Regents Of The University California Compositions, methods for regulating uterine, placental growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
HU180443B (en) * 1979-04-02 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a pharmaceutical preparation with synergetic action against radiation
NL8502092A (nl) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma Tabletten die s-carboxymethylcysteine bevatten en werkwijze voor de bereiding daarvan.
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (es) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat

Also Published As

Publication number Publication date
DE59106133D1 (de) 1995-09-07
EP0481294A1 (de) 1992-04-22
EP0481294B1 (de) 1995-08-02
GR3017499T3 (en) 1995-12-31
ATE125702T1 (de) 1995-08-15
DK0481294T3 (da) 1995-11-27
EP0481294B2 (de) 2001-04-11
DK0481294T4 (da) 2001-06-18
US5401514A (en) 1995-03-28
ES2077757T5 (es) 2001-06-01

Similar Documents

Publication Publication Date Title
ES2077757T3 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la s-(carboximetil)-l-cisteina y/o la n-acetilcisteina.
ES2103836T3 (es) Suspensiones biocidas y agroquimicas.
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
DK0501985T3 (da) Uovertrukket farmaceutisk reaktionstablet
DK214689A (da) Farmaceutiske midler
SE8902288D0 (sv) Farmaceutisk komposition
SE8702941L (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
ATA180191A (de) Furanderivate enthaltende pharmazeutische präparate
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATE81000T1 (de) Stabilisierte, n-acetylcysteinhaltige arzneimittelzubereitung.
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
RU92015628A (ru) Состав для дезинфекции объектов пчеловодства
RU98105696A (ru) Средство для лечения и профилактики болезней полости рта
ATE102031T1 (de) Pharmazeutische zubereitung.
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.
ATE15139T1 (de) Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
KR890003367A (ko) 심장질환 치료용 조성물
RU92009797A (ru) Дезинфицирующий водный раствор для стоматологических оттисков
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 481294

Country of ref document: ES